- | Pays :
- France
- Former Serbia and Montenegro
- Romania
- Les 8 autres...
- | Organes : -
- | Spécialités : -
Extrait
The rationale of the study was to evaluate different degarelix dosing regimens for a three-month interval that was to produce and maintain castration in prostate cancer patients through immediate and prolonged testosterone suppression, and to provide confirmatory evidence of the safety of degarelix.
Critère d'inclusion
- Prostate cancer